September 4, 2020
Janssen, Johnson & Johnson’s pharma subsidiary, is looking to the digital health startup space for new ideas on predictive diagnostics and precision treatment. The company has launched a new nine-month startup accelerator focused on the Europe, Middle East and Africa (EMEA) region.
Startups will have until Sept 27 to apply to the accelerator and must focus their pitch around ways to improve...
February 25, 2020
Apple and Johnson & Johnson announced this morning the launch of their new digital health study exploring the impact of Apple’s devices and a study-specific engagement program on cardiovascular outcomes among the Medicare population.
First announced in early 2019, the Heartline Study — which also names Evidation Health as a collaborator — is now enrolling seniors aged 65 years or older who...
Photo courtesy of Janssen Pharmaceutical Companies. From left to right: panel moderator Patrick Wayte, Dr. C. Michael Gibson and Dr. Paul Stoffels.
November 18, 2019
Due to the promises of lower costs, simple scaling and greater patient engagement, digital technologies are all but an inevitability for the drug trials of tomorrow, according to experts from pharma and the clinical research community speaking this weekend at the American Heart Association Scientific Sessions in Philadelphia.
These comments were accompanied by the official kickoff of CHIEF-HF,...
June 20, 2019
Singapore-headquartered digital health and data analytics company Holmusk signed a Memorandum of Understanding (MoU) with Janssen (China) Research & Development Centre (Janssen), to explore the development of a digital mental health strategy in China.
Based on the MoU, Holmusk and Janssen propose to focus on generating insights from real-world data on depression and other mental health...
October 11, 2017
Janssen Research and Development, a Johnson & Johnson subsidiary, will launch the first clinical trial to use its iSTEP technology toolset, which employs smart blisterpacks and a patient-facing smartphone app, by the end of the year. iSTEP, which stands for Integrated Smart Trial and Engagement Platform, has been under development at Janssen for five years.
“The mission of Janssen as an...
May 8, 2017
Japanese health app maker Welby announced three new apps last month developed in partnership with pharma companies. Welby will add to its lineup three apps available only in Japan: an app for irritable bowel disease patients with Johnson & Johnson subsidiary Janssen; an app for pulmonary arterial hypertension (PAH) patients with Japanese pharma company Nippon Shinyaku, and an app for...
December 27, 2012
Omniscience Mobile's upcoming clinical trial app.
Mobile technology presents a sorely-needed, long-awaited opportunity for innovating the clinical trial – making it cheaper, easier, and even more accurate. But there are a lot of pieces to a clinical trial, and, according to some, mobile technology has the capacity to influence almost every one. Different companies are experimenting with these...
October 16, 2012
The latest in a growing line of accelerators for small digital health companies is distinct from many of the others in that it is backed in part by public money and the mentors are provider organizations seeking technological help in delivering better, more efficient care. It also claims to be the best-funded health IT accelerator in the nation, with an initial commitment of $4.2 million.
August 2, 2012
This week a new San Francisco-based startup, Mango Health, which is developing a medication adherence app with social gaming elements, announced that it had scooped up $1.45 million in venture funding. Investors include Floodgate Fund, First Round Capital, Steve Anderson with Baseline Ventures, Zynga co-founder and CEO Mark Pincus and Square COO Keith Rabois, according to GigaOM.
A handful of...